loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 20986 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN ASPART RECOMBINANT (5)

filter

01 NOVO NORDISK INC (5)

filter

01 INJECTABLE;SUBCUTANEOUS (5)

filter

01 1000 UNITS/10ML (100 UNITS/ML) (1)

02 300 UNITS/3ML (100 UNITS/ML) (4)

filter

01 USA (5)

URL Supplier Web Content
INJECTABLE;SUBCUTANEOU...
300 UNITS/3ML (100 UNI...
NOVOLOG FLEXPEN
USA
20986
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;SUBCUTANEOU...
1000 UNITS/10ML (100 U...
NOVOLOG
USA
20986
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;SUBCUTANEOU...
300 UNITS/3ML (100 UNI...
NOVOLOG INNOLET
USA
20986
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;SUBCUTANEOU...
300 UNITS/3ML (100 UNI...
NOVOLOG PENFILL
USA
20986
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;SUBCUTANEOU...
300 UNITS/3ML (100 UNI...
NOVOLOG FLEXTOUCH
USA
20986
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 20986

Looking for CTD TGA MCC DOSSIER APPLICATION 20986 5

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART RECOMBINANT, with a corresponding application number 20986 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLOG FLEXPEN INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN ASPART RECOMBINANT.

18

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART RECOMBINANT, with a corresponding application number 20986 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLOG INJECTABLE;SUBCUTANEOUS, medication with 1000 UNITS/10ML (100 UNITS/ML) of INSULIN ASPART RECOMBINANT.

17

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART RECOMBINANT, with a corresponding application number 20986 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLOG INNOLET INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN ASPART RECOMBINANT.

16

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART RECOMBINANT, with a corresponding application number 20986 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLOG PENFILL INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN ASPART RECOMBINANT.

15

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART RECOMBINANT, with a corresponding application number 20986 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLOG FLEXTOUCH INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN ASPART RECOMBINANT.

Post Enquiry
POST ENQUIRY